These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 12025847

  • 1. The WLF case thus far: not with a bang, but a whimper.
    Cooper RM.
    Food Drug Law J; 2000; 55(4):477-89. PubMed ID: 12025847
    [No Abstract] [Full Text] [Related]

  • 2. A global view of the First Amendment constraints of FDA.
    Carver KH.
    Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459
    [No Abstract] [Full Text] [Related]

  • 3. "It's time to make a good agency better": the Food and Drug Administration Modernization Act of 1997 and the First Amendment.
    Murphy AM.
    Food Drug Law J; 1998; 53(4):603-25. PubMed ID: 10557579
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. First Amendment limits on regulating information: an initial reaction to the Washington Legal Foundation case.
    Gibbs JN.
    Food Drug Law J; 1998; 53(4):597-601. PubMed ID: 10557578
    [No Abstract] [Full Text] [Related]

  • 7. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN, Ferrari PL, Murphy AM, Hyman, Phelps & McNamara, P.C., Washington, D.C., USA.
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract] [Full Text] [Related]

  • 8. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ.
    Food Drug Law J; 1996; 51(2):323-9. PubMed ID: 11822325
    [No Abstract] [Full Text] [Related]

  • 9. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J, Brophy E, Rother P.
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Surfing the Net in shallow waters: product liability concerns and advertising on the Internet.
    Moberg MA, Wood JW, Dorfman HL.
    Food Drug Law J; 1998; 53(2):213-24. PubMed ID: 10346682
    [No Abstract] [Full Text] [Related]

  • 12. The Dietary Supplement Health and Education Act.
    Young AL, Bass IS.
    Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995
    [No Abstract] [Full Text] [Related]

  • 13. Smoking and the First Amendment.
    Outterson K.
    N Engl J Med; 2011 Dec 22; 365(25):2351-3. PubMed ID: 22149735
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS.
    Food Drug Law J; 1996 Dec 22; 51(3):355-65. PubMed ID: 11797712
    [No Abstract] [Full Text] [Related]

  • 16. Pediatric marketing exclusivity--as altered by the Best Pharmaceuticals for Children Act of 2002.
    Cooper KJ.
    Food Drug Law J; 2002 Dec 22; 57(3):519-44. PubMed ID: 12710409
    [No Abstract] [Full Text] [Related]

  • 17. Legal overview of likely FDA regulation of Internet promotion.
    Scheineson MJ.
    Food Drug Law J; 1996 Dec 22; 51(4):697-716. PubMed ID: 11797736
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Supreme Court checks out drug promotion restrictions.
    Gilhooley M.
    Food Drug Law J; 2003 Dec 22; 58(3):347-52. PubMed ID: 14626982
    [No Abstract] [Full Text] [Related]

  • 20. Health care law.
    Mayo TW.
    SMU Law Rev; 2003 Dec 22; 56(3):1767-82. PubMed ID: 12924424
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.